Psychomotor stimulants

15,053views

Psychomotor stimulants

End of Rotation™ exam review

ENOT and ophthalmology

Anatomy clinical correlates: Skull, face and scalp
Anatomy clinical correlates: Temporal regions, oral cavity and nose
Anatomy clinical correlates: Eye
Anatomy clinical correlates: Ear
Anatomy clinical correlates: Vessels, nerves and lymphatics of the neck
Anatomy clinical correlates: Viscera of the neck
Anatomy clinical correlates: Olfactory (CN I) and optic (CN II) nerves
Anatomy clinical correlates: Oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Anatomy clinical correlates: Trigeminal nerve (CN V)
Anatomy clinical correlates: Facial (CN VII) and vestibulocochlear (CN VIII) nerves
Anatomy clinical correlates: Glossopharyngeal (CN IX), vagus (X), spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Eye conditions: Inflammation, infections and trauma: Pathology review
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Acute group A streptococcal infections and sequelae (pediatrics): Clinical sciences
Allergic rhinitis: Clinical sciences
Approach to amblyopia and strabismus (pediatrics): Clinical sciences
Approach to complications of prematurity (late): Clinical sciences
Conjunctival disorders: Clinical sciences
Croup and epiglottitis: Clinical sciences
Otitis media and externa (pediatrics): Clinical sciences
Periorbital and orbital cellulitis (pediatrics): Clinical sciences
Pharyngitis, peritonsillar abscess, and retropharyngeal abscess (pediatrics): Clinical sciences
Antihistamines for allergies

Gastrointestinal and nutritional system

Anatomy clinical correlates: Inguinal region
Anatomy clinical correlates: Peritoneum and diaphragm
Anatomy clinical correlates: Viscera of the gastrointestinal tract
Anatomy clinical correlates: Other abdominal organs
Appendicitis: Pathology review
Congenital gastrointestinal disorders: Pathology review
Fat-soluble vitamin deficiency and toxicity: Pathology review
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Jaundice: Pathology review
Malabsorption syndromes: Pathology review
Viral hepatitis: Pathology review
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Water-soluble vitamin deficiency and toxicity: B9, B12 and vitamin C: Pathology review
Zinc deficiency and protein-energy malnutrition: Pathology review
Appendicitis: Clinical sciences
Approach to abdominal wall defects: Clinical sciences
Approach to acute abdominal pain (pediatrics): Clinical sciences
Approach to chronic abdominal pain (pediatrics): Clinical sciences
Approach to connective tissue disorders: Clinical sciences
Approach to constipation (pediatrics): Clinical sciences
Approach to diarrhea (pediatrics): Clinical sciences
Approach to head and neck masses (pediatrics): Clinical sciences
Approach to hematochezia (pediatrics): Clinical sciences
Approach to jaundice (conjugated hyperbilirubinemia): Clinical sciences
Approach to jaundice (newborn and infant): Clinical sciences
Approach to jaundice (unconjugated hyperbilirubinemia): Clinical sciences
Approach to medication exposure (pediatrics): Clinical sciences
Approach to melena and hematemesis (pediatrics): Clinical sciences
Approach to poor feeding (newborn and infant): Clinical sciences
Approach to the acute abdomen (pediatrics): Clinical sciences
Approach to vomiting (newborn and infant): Clinical sciences
Approach to vomiting (pediatrics): Clinical sciences
Dehydration (pediatrics): Clinical sciences
Foreign body aspiration and ingestion (pediatrics): Clinical sciences
Hepatitis A and E: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis C: Clinical sciences
Infectious gastroenteritis (acute) (pediatrics): Clinical sciences
Infectious gastroenteritis (subacute) (pediatrics): Clinical sciences
Inguinal hernias: Clinical sciences
Intussusception: Clinical sciences
Pyloric stenosis: Clinical sciences
Umbilical hernias: Clinical sciences
Acid reducing medications
Antidiarrheals
Laxatives and cathartics

Neurology and developmental

Autosomal trisomies: Pathology review
Central nervous system infections: Pathology review
Disorders of sex chromosomes: Pathology review
Seizures: Pathology review
Developmental milestones (childhood): Clinical sciences
Developmental milestones (newborn and infant): Clinical sciences
Developmental milestones (toddler): Clinical sciences
Immunizations (pediatrics): Clinical sciences
Sports physical (pediatrics): Clinical sciences
Well-child visit (adolescent): Clinical sciences
Well-child visit (newborn and infant): Clinical sciences
Well-child visit (toddler and child): Clinical sciences
Approach to a child with Down syndrome (trisomy 21): Clinical sciences
Approach to a first unprovoked seizure (pediatrics): Clinical sciences
Approach to a suspected brain tumor (pediatrics): Clinical sciences
Approach to aneuploidies and microdeletions: Clinical sciences
Approach to atypical genitalia: Clinical sciences
Approach to complications of prematurity (late): Clinical sciences
Approach to delay or regression in developmental milestones: Clinical sciences
Approach to delayed puberty: Clinical sciences
Approach to growth faltering: Clinical sciences
Approach to neurocutaneous syndromes: Clinical sciences
Approach to precocious puberty: Clinical sciences
Approach to prenatal teratogen exposure: Clinical sciences
Approach to trauma (pediatrics): Clinical sciences
Febrile seizure (pediatrics): Clinical sciences
Meningitis (pediatrics): Clinical sciences
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants

Transcript

Watch video only

Psychomotor stimulants are drugs that stimulate the central nervous system to increase motor activity and to produce euphoria, excitement, and a feeling of having lots of energy.

Unfortunately, some drugs of abuse, like methamphetamine or cocaine, belong to this class of substances.

However, there are a few medications in this class that do have clinical applications so let’s go over those.

To understand how psychomotor stimulants work, let’s zoom in on one of the synapses of the brain.

Normally electrical signals, or action potentials, travel down the axon to the axon terminal, where they trigger the release of chemical messengers, called neurotransmitters, from synaptic vesicles into the synapse.

The neurotransmitters travel across the synapse and bind to receptors on the postsynaptic neuron, where they give the cell a message.

After the neurotransmitters have done their job, they unbind from the receptors, and can: diffuse away, get degraded by enzymes, or get picked up by proteins and returned to their original release site in a process called reuptake.

Psychomotor stimulants, in general, increase the release of certain neurotransmitters, but their biggest effect is blocking reuptake receptors on presynaptic axon terminals.

Both actions keep neurotransmitters - like dopamine, norepinephrine, and serotonin - in the synapse longer, and increases their effects.

For example, increased concentrations of dopamine in the brain’s reward pathway, which includes the nucleus accumbens, ventral tegmentum, and prefrontal cortex, produce intense feelings of euphoria, pleasure, and the emotional “high” associated with psychomotor stimulants.

The physical “high” or feeling of hyper-stimulation is caused by increased norepinephrine concentrations throughout the brain, which produces a variety of effects throughout the body like increased energy, constricted blood vessels, dilated pupils, increased body temperature, increased heart rate, and increased blood pressure.

And finally, higher levels of serotonin are associated with greater confidence and happiness, and decreased anxiety.

Okay, for psychomotor stimulants with medical applications, let’s start with the popular methylxanthines.

We are all familiar with this class of medication since it includes caffeine and theophylline found in coffee and tea respectively.

Now both these substances cause a stimulatory effect by blocking receptors for adenosine, a chemical that has numerous effects in the body like decreasing heart rate, decreasing neuronal activity - triggering sleepiness, and dilating blood vessels.

Now, migraines and other headaches can be caused by increased adenosine levels in the brain, so caffeine is often combined with an NSAID or acetaminophen to treat them.

Theophylline, on the other hand, is used to treat respiratory disorders like COPD and asthma.

It works by inhibiting the enzyme phosphodiesterase, or PDE, in the smooth muscles in the respiratory tract.

Normally phosphodiesterase converts cAMP into an inactive form called 5-AMP.

By inhibiting this enzyme, we increase the level of cAMP within the cell, and trigger smooth muscle relaxation and bronchodilation.

An overdose of methylxanthines can cause anxiety, nausea, arrhythmia, and seizures, so watch your coffee intake!

Another medication that can help you stay awake is Modafinil.

It’s mainly used to treat narcolepsy, a condition where the person can fall asleep at any moment of the day and has episodes of paralysis out of the blue - not cool, right?

Well, modafinil inhibits dopamine reuptake and increases the release of glutamate and histamine in the brain, all of which increases arousal.

Modafinil is sometimes used as a “cognitive enhancer” off-label, but there’s no research to support this claim.

Okay, let’s move on to the next group of medication like amphetamines and methylphenidate which work by blocking the reuptake of dopamine and norepinephrine at the presynaptic neuron.

It’s the preferred treatment for attention deficit/hyperactivity disorder, or ADHD for short, because it helps improve focus and decreases the impulsivity common in people with this disorder.

It also doesn’t have major side effects, making it the preferred medication.

Finally, we have cocaine, sometimes called coke, which is a powerful psychomotor stimulant that has been used for over a thousand years.

Key Takeaways

Psychomotor stimulants are medications that stimulate the central nervous system to increase alertness, attention, and energy levels. Some psychomotor stimulants, like modafinil, methylphenidate, and cocaine work by increasing the amount of dopamine, norepinephrine, and serotonin in the synapse by preventing their reuptake. Others, like the methylxanthines, block the action of adenosine, which normally decreases neuronal activity and causes drowsiness. Common side effects include agitation; insomnia, tachycardia, hypertension, tics, and anorexia.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Behavioral effects of caffeine and other methylxanthines on children" Exp Clin Psychopharmacol (1998)
  5. " Caffeine and theophylline counteract diazepam effects in man" Med Biol (1983)
  6. "Amphetamine, past and present--a pharmacological and clinical perspective" J Psychopharmacol (Oxford) (2013)
  7. "Autonomic actions of cocaine" Can J Physiol Pharmacol (1989)
  8. "Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review" Eur Neuropsychopharmacol (2015)